January 25, 2022

Day: January 13, 2022

PRESS RELEASES

Madison Realty Capital Originates $345 Million Loan for St. Regis Residences on Boston Waterfront

NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) — Madison Realty Capital, a vertically integrated real estate private equity firm focused on debt and equity investment strategies, today announced that it has originated a $345 million loan to Cronin Development for the completion of a 22-story, 114-unit residential and retail condominium development at 150 Seaport Boulevard […]

Read More
PRESS RELEASES

STACK Infrastructure expands APAC footprint with new 36MW campus in Inzai, Japan

Milestone follows recent announcement of STACK’s entrance to APAC market with the opening of its Singapore regional headquarters DENVER, SINGAPORE and TOKYO, Jan. 13, 2022 (GLOBE NEWSWIRE) — STACK Infrastructure (“STACK” or the “Company”), the digital infrastructure partner to the world’s most innovative companies, today announced a partnership with funds managed by Oaktree Capital Management, L.P. (“Oaktree”), […]

Read More
PRESS RELEASES

HAS Healthcare Advanced Synthesis launches as an independent business

HAS Healthcare Advanced Synthesis launches as an independent business Biasca, Switzerland, January 13, 2022 – HAS Healthcare Advanced Synthesis SA (the “Company”), a full-service contract development and manufacturing organization (CDMO) delivering high-quality, exclusive, personalized solutions to its healthcare clients, today announces its launch as an independent business. Originally established as part of the Helsinn Group by the Braglia family, under the name […]

Read More
PRESS RELEASES

Remington and Manchester United Extend Partnership

Manchester United Head of Academy Highlights Importance of Individuality and Confidence for Young Players Remington Extends Partnership with Manchester United MANCHESTER, England, Jan. 13, 2022 (GLOBE NEWSWIRE) — Spectrum Brands Holdings, Inc. (NYSE: SPB) and Manchester United (NYSE: MANU) jointly announced today the extension of their global partnership, which will see Spectrum Brands’ iconic Remington […]

Read More
PRESS RELEASES

Adagio Therapeutics Summarizes ADG20 Neutralizing Activity Against SARS-CoV-2 Variants and Outlines Initiatives to Address Omicron

Recent Publications by Several Independent Laboratories Show ADG20 Has Neutralizing Activity with Potency Comparable to Other Antibodies that Retain Activity Against Omicron Multiple Efforts Underway to Address Omicron and Potential Future SARS-CoV-2 Variants WALTHAM, Mass., Jan. 12, 2022 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI), a clinical-stage biopharmaceutical company focused on the discovery, development […]

Read More